Evidence mapPaperPMID 41907282Full record

ArticleFrontiers in medicine2026

The efficacy of electroacupuncture combined with Micro-Needle-Knife for allergic rhinitis: study protocol for a randomized controlled trial.

Pengfei Qiu, Xue Wu, Ning Ye, Xiaofang Zhou, Jianfang Zhu, Xiayang Zeng

Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06890260 (A Clinical Randomized Controlled Study of Electroacupuncture Combined With Microneedle Knife in the Treatment of Moderate to Severe Allergic Rhinitis), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06890260 narecruitingnot on this map

A Clinical Randomized Controlled Study of Electroacupuncture Combined With Microneedle Knife in the Treatment of Moderate to Severe Allergic Rhinitis

TypeinterventionalSponsorPengfei QiuRan2025 to 2027Enrolled90ConditionsAllergic Rhinitis (Disorder), Electroacupuncture, Microneedle KnifeArmsElectroacupuncture combined with Microneedle Knife, Cetirizine hydrochloride tablets combined with nasal budesonide spray.
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pengfei QiuDepartment of Acupuncture and Moxibustion, Zhejiang Hospital, Hangzhou City, Zhejiang, China.
Xue WuThe Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou City, Zhejiang, China.
Ning YeDepartment of Laboratory Medicine, Zhejiang Hospital, Hangzhou City, Zhejiang, China.
Xiaofang ZhouDepartment of Otolaryngology, Zhejiang Hospital, Hangzhou City, Zhejiang, China.
Jianfang ZhuDepartment of Acupuncture and Moxibustion, Zhejiang Hospital, Hangzhou City, Zhejiang, China.
Xiayang ZengDepartment of Tui Na, Zhejiang Hospital, Hangzhou City, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Allergic rhinitis (AR), classified as a hypersensitivity disorder profoundly impairing human quality of life, presents substantial clinical complexities. Among these, the management of moderate-to-severe AR cases constitutes a particularly challenging clinical scenario, which seriously affects their daily life, study, sleep, and mood. The efficacy of conventional treatments for AR remains suboptimal, necessitating an urgent exploration of alternative approaches to identify simpler, more convenient, effective, and cost-efficient therapeutic options for clinical AR management. This trial is designed to rigorously assess the efficacy and safety of electroacupuncture (EA) combined with Micro-Needle-Knife therapy as a novel therapeutic modality for patients with moderate-to-severe allergic rhinitis. Methods and analysis: This study protocol is a randomized controlled, patient-assessor-blinded trial. The trial will have a treatment period of 4 weeks and a follow-up period of 3 months. 90 eligible participants will be randomly assigned to the EA combined with Micro-Needle-Knife group and the drug group in a 1:1 ratio. The evaluation of all study parameters will be conducted across five distinct temporal phases: baseline assessment (week 0), two consecutive intervention phases (weeks 2 and 4), and two subsequent follow-up intervals (weeks 8 and 16). The primary outcome is the Total Nasal Symptom Score (TNSS). Secondary outcomes include Total Non-nasal Symptom Score (TNNSS), Rhinitis Quality of Life Questionnaire (RQLQ), serum chemokine Eotaxin, Inter Cellular Adhesion Molecule-1 (ICAM-1), and Eosinophil Cationic Protein (ECP). All adverse events will be evaluated during the trial. Conclusions: This study will preliminarily evaluate if EA combined with Micro-Needle-Knife is effective and safe in the treatment of AR. Clinical trial registration: https://clinicaltrials.gov/study/NCT06890260; identifier: NCT06890260.

Indexed as

allergic rhinitiselectroacupunctureMicro-Needle-Knifeprotocolrandomized controlled trial

Identifiers

PMID41907282
PMCPMC13021446

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.